Predictive analytics technologies in the management of the COVID‑19 pandemic

2020 ◽  
pp. 24-33
Author(s):  
A. V. Gusev ◽  
◽  
R.E. Novitsky ◽  

Recently, a new coronavirus infection, or COVID‑19, caused by the pathogen SARS-CoV‑2, has been continuing to spread around the world rapidly. According to the World Health Organization (WHO), which declared this outbreak a pandemic, COVID‑19 is a serious public health problem of international concern. Due to the lack of proven effective treatment and vaccination against COVID‑19, precautions are considered by WHO to be strategic goals and a primary response to the pandemic. It is recommended that country guidelines adopt national health care programs aimed at assessing and reducing the risk of infection spread. Predictive analytics have begun to be actively used to compile population and personal forecasts of the progression of morbidity, mortality, assess the severity of the course of the disease, etc. This article provides an overview of available developments and publications on the use of predictive analytics in the management of COVID‑19 pandemic.

2021 ◽  
Vol 7 (1) ◽  
pp. 24-32
Author(s):  
Semen Kireev ◽  
I. Popov ◽  
A. Ban'kovskiy ◽  
E. Litvinenko ◽  
E. Surova

At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Re-public of China with an epicenter in the city of Wuhan (Hubei province). On February 11, 2020, the World Health Organization has assigned the official name of the infection caused by the new coronavirus - COVID-19 ("Coronavirus disease2019"). On February 11, 2020, the International Committee on Virus Taxonomy gave the official name to the infectious agent - SARS-CoV-2.Since the end of January 2020, cases of COVID-19 have begun to be registered in many coun-tries of the world, mainly associated with travel to the PRC. At the end of February 2020, the epidemiological situation with COVID-19 in South Korea, Iran and Italy sharply worsened, which subsequently led to a significant increase in the number of cases in other countries of the world associated with travel to these countries, incl. and in Russia. The World Health Organiza-tion announced the COVID-19 pandemic on 11 March 2020, and the pandemic's challenge to the world will remain so as long as people are not immune to it.The Regional Director of the World Health Organization Takeshi Kasai, on the basis of an epidemiological analysis, reports that the spread of coronavirus infection COVID-19 in July-August 2020 occurred mainly among people under 50 years old, and they often did not even know about it, because they had mild or no symptoms. In the future, these people then infect older people who are more difficult to tolerate COVID-19. And we need to redouble our efforts to prevent the spread of the virus in vulnerable communities.


Author(s):  
Pedro Castro ◽  
Ana Paula Matos ◽  
Heron Werner ◽  
Flávia Paiva Lopes ◽  
Gabriele Tonni ◽  
...  

AbstractSince the World Health Organization (WHO) declared coronavirus infection (COVID-19) a Public Health Emergency of International Concern in January 2020, there have been many concerns about pregnant women and the possible effects of this emergency with catastrophic outcomes in many countries. Information on COVID-19 and pregnancy are scarce and spread throughout a few case series, with no more than 50 cases in total. The present review provides a brief analysis of COVID-19, pregnancy in the COVID-19 era, and the effects of COVID-19 on pregnancy.


Crisis ◽  
1998 ◽  
Vol 19 (4) ◽  
pp. 172-176 ◽  
Author(s):  
Murad Moosa Khan

Suicide and attempted suicide are understudied subjects in Pakistan, an Islamic country where they are considered criminal offenses. National suicide statistics are not compiled nor are suicide mortality statistics reported to the World Health Organization (WHO). Although there are strong religious sanctions against suicide, there are no clear principles against attempted suicide in Islam. Despite this, Pakistan, like many other Islamic countries, has punitive laws against attempted suicide. This has led to both suicide and attempted suicide being underdiagnosed and underreported. Data on suicide and attempted suicide are also difficult to obtain. This article gives an overview of the current state of suicide and attempted suicide in Pakistan, in the context of existing religious and legal factors, highlighting the main findings of the few studies carried out over the last 50 years. It is important that researchers in Islamic countries like Pakistan not be deterred by the apparent low rates of suicide in these countries, but conduct further research in this important yet neglected public-health problem.


Parasitology ◽  
1987 ◽  
Vol 94 (S1) ◽  
pp. S159-S179 ◽  
Author(s):  
I. A. McGregor

Throughout the world, infection with parasites is extremely common. Prevalence is highest in the warm countries of the tropics and subtropics, but infection occurs in all climatic zones. The figures usually quoted for the prevalence of specific parasites attain values akin to those used to describe astronomical distances. The World Health Organization (1985) estimated that some 2582 million of the earth's inhabitants live in areas where they risk contracting malaria and that many – in Africa south of the Sahara alone probably 200 million – remain chronically and persistently infected. Estimates for other parasites are similarly impressive; 600 million at risk of infection with schistosomiasis, with some 200 million actually infected; 900 million exposed to lymphatic filarial parasites, with some 90 million currently infected; for onchocerciasis, probably some 40 million cases spread throughout Africa, Central and South America and the Eastern mediterranean. Yet, impressive as these estimates may be, they are dwarfed by those for some intestinal helminths. Recent assessments suggest that 1 person in 4 of the world's population carries Ascaris lumbricoides (Schultz, 1982), while the same proportion is believed to be infected with one or other of the hookworms (Gilman, 1982).


2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Iara Fabricia Kretzer ◽  
Andrea do Livramento ◽  
Joel da Cunha ◽  
Sabrina Gonçalves ◽  
Iraci Tosin ◽  
...  

Hepatitis C virus (HCV) is endemic worldwide and according to the World Health Organization (WHO), there are about 150 million chronic carriers worldwide. The infection is a leading cause of liver diseases like cirrhosis and hepatocellular carcinoma (HCC); thus, HCV infection constitutes a critical public health problem. There are increasing efforts worldwide in order to reduce the global impact of hepatitis C through the implementation of programmatic actions that may increase the awareness of viral hepatitis and also improve surveillance, prevention, and treatment. In Brazil, about 1,5 million people have been chronically infected with HCV. The country has a vast territory with uneven population density, and hepatitis C incidence rates are variable with the majority of cases concentrated in the most populated areas. Currently, the main priorities of Brazilian Ministry of Health's strategies for viral hepatitis management include the prevention and early diagnosis of viral hepatitis infections; strengthening of the healthcare network and lines of treatment for sexually transmitted diseases, viral hepatitis, and AIDS; improvement and development of surveillance, information, and research; and promotion of universal access to medication. This review aims to summarize the available data on hepatitis C epidemiology and current status of efforts in prevention and infection control around the world and in Brazil.


Author(s):  
S.A. Yeprintsev ◽  
◽  
O.V. Klepikov ◽  
S.V. Shekoyan ◽  
E.V. Zhigulina ◽  
...  

The spread of the dangerous Covid-19 infection caused by the SARS-CoV-2 coronavirus since the end of 2019 has become a great challenge to both the world and Russian society. For example, on January 30, 2020, the world health organization recognized the spread of a new infection as a public health emergency of international significance. On March 11, 2020, the same organization declared that the outbreak had become a pandemic. currently, the role of social and environmental factors (which determine the spread of many environmentally-related diseases) in the spread of coronavirus infection in the population has not been fully studied. The spread of Covid-19 infection in Russia can be divided into 3 stages. Stage 1 (31.01.2020–01.04.2020) – primary distribution. At this stage, the infection occurred mainly to Russian citizens visiting other countries. Stage 2 (1.04.2020– 12.05.2020) – active distribution within the country. By the end of this stage, the maximum spread of infection is recorded. Stage 3 (12.05.2020-present) – gradual decline in the appearance of new cases of coronavirus infection. To assess the specific contribution of socio-environmental conditions to the spread of coronavirus infection, data from the Federal information Fund for social and hygienic monitoring of the Federal CENTER for hygiene and epidemiology of Rospotrebnadzor were analyzed on indicators of financial security of citizens, quality of health care and sanitary and hygienic conditions. Research has shown that financial security of the population makes a significant contribution to the spread of infection at the first stages. The specific contribution of the quality of medical care, which has a wide differentiation within the regions of Russia, affects only the third stage of the spread of coronavirus infection. Environmental and hygiene indicators make a weak contribution to the spread of Covid-19 in all three stages of the epidemic.


2021 ◽  
pp. 2-2
Author(s):  
Mariia Pavlushenko ◽  
Roman Liubota ◽  
Roman Vereshchako ◽  
Nikolay Anikusko ◽  
Irina Liubota

The biggest challenge for the World Health Organization today is the fight against the COVID-19 pandemic. The current situation prompted major adjustments in the system of cancer care. In this review, we investigate the aspects of cancer treatment and care during the pandemic, since in this setting oncological services face challenges in determining the feasibility of anticancer treatments while minimizing the risk of infection. Cancer patients are at a higher risk from COVID-19 disease. Therefore, oncological community is discussing on the priorities for providing cancer therapies and care and at the same time minimizing the risk of infection.


2018 ◽  
Vol 8 (1) ◽  
pp. 54
Author(s):  
Ana Paula Reis de Oliveira ◽  
Chalana Duarte Sena ◽  
Gilvânia Patrícia Do Nascimento Paixão ◽  
Josinete Gonçalves dos Santos Lírio

Considerada pela Organização Mundial de Saúde (OMS) como problema de saúde pública, a violência contra a mulher (VCM) é uma epidemia mundial, estima-se que as mulheres em vivência de violência doméstica, ao longo de suas vidas, apresentam mais problemas de saúde e buscam, com mais frequência os serviços de saúde do que pessoas que não sofrem estes maus tratos. Diante do exposto, o presente estudo tem como objetivo: Identificar os fatores que facilitam e dificultam a assistência a saúde a mulher em situação de violência domestica segundo a literatura brasileira, visando à importância da identificação das mulheres em vivência de violência e a ampliação deste cuidado não apenas para a cura/tratamento, mas para o vínculo e acolhimento eficaz e humano entre o agente cuidador e o agente alvo de cuidados, visando à superação tanto do cenário atual, quanto de tal momento doloroso na vida na mulher.Descritores: Violência Doméstica e Sexual Contra a Mulher; Cuidados; associados ao uso do recurso booleano “AND”. ABSTRACT Considered by the World Health Organization (WHO) as a public health problem, violence against women (VCM) is a worldwide epidemic, it is estimated that women experiencing domestic violence throughout their lives have and seek health services more often than people who do not suffer from these ill-treatment. In view of the above, the present study aims to: Identify the factors that facilitate and hinder the health care of women in situations of domestic violence according to the Brazilian literature, aiming at the importance of identifying women in the experience of violence and the expansion of this care not only for the cure/treatment, but for the effective and humane bonding and reception between the caregiver agent and the target agent of care, aiming at overcoming both the current scenario and that painful moment in life in the woman. Descriptors: Domestic and Sexual Violence Against Women; Care; associated with the use of the boolean "AND".


Indian pharmaceutical industry (IPI) has traversed through many phases and it is in emerging phase now (2019). IPI is looking for innovation, creativity, newness in patient connect to perform different activities to achieve their stated goals. According to a recent World Health Organization report, approximately 50% of the people with chronic illness do not take their medication as prescribed [1]. Medication NonAdherence is a huge problem across the world. Pharmaceutical companies across the world manufacture medicines with set of standard operating procedures, guidelines, quality execution systems, inspection and verification from quality control and quality assurance activities. The very intention of producing medicines is to sell them to the patients who are in need. The last thing Pharmaceutical companies expects from Health Care Professional (HCP) is to write the prescription and patient carrying it to Pharmacy to buy the medicine. The medicines for chronic illness are expensive in general. Despite having the prescriptions for medicines, there are plethora of reasons for Patient not to buy them. One of the most remarkable reason is – ‘the medicine costs are exorbitant’. If the medicines are not taken in case of the chronic illness, the patient’s quality of life degrades over a period of time, eventually resulting to fatality. This is a known concern to Pharmaceutical companies and new methods are invented to address the need for supporting the Patient at difficult times. This paper made an attempt to introduce predictive analytics based financial assistance model for chronic care patients in India.


2020 ◽  
pp. 1-5
Author(s):  
Tamar Etzioni-Friedman ◽  
Amos Etzioni

Immunizations have been saving the lives of millions of people since they were first used by Edward Jenner in 1796, and new vaccines are being developed all the time. Hopefully, a new vaccine for coronavirus disease 2019 (COVID-19) will be developed in the near future, and perhaps even one for human immunodeficiency virus. Although the effectiveness of vaccinations has been proven over the years and adverse effects to currently available vaccinations are extremely rare, many people continue to defer immunizations for themselves and their families. According to the World Health Organization (WHO), this phenomenon, known as “vaccine hesitancy,” is a major public health problem globally. This review summarizes the unproven adverse effects of various vaccines and stresses the importance of enforcing vaccination policies to minimize vaccine hesitancy. Every effort should be made to improve existing vaccines and to produce new ones, according to carefully designed scientific preclinical and clinical trials. This is particularly important in today’s era, in light of the global transparency regarding vaccination development, and the potential for future pandemics such as COVID-19.


Sign in / Sign up

Export Citation Format

Share Document